Biofrontera Inc.
BFRI
$0.90
-$0.0219-2.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.81% | 50.09% | 11.78% | 51.45% | 40.40% |
| Total Depreciation and Amortization | -16.18% | -3.98% | 7.99% | -20.94% | -18.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.62% | -832.94% | 108.93% | -288.50% | -398.86% |
| Change in Net Operating Assets | 1,352.02% | 218.04% | 241.37% | 125.86% | 92.70% |
| Cash from Operations | 50.37% | 54.91% | 58.75% | 25.44% | 33.01% |
| Capital Expenditure | -- | 191.67% | -100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -107.34% | -98.88% | 104.66% | 109.17% |
| Cash from Investing | -101.10% | -100.95% | -100.48% | 104.61% | 109.14% |
| Total Debt Issued | -79.28% | -83.96% | -83.96% | -13.61% | 242.95% |
| Total Debt Repaid | 98.57% | 89.43% | 79.78% | -16.55% | -352.05% |
| Issuance of Common Stock | -100.00% | -100.00% | 70.00% | -- | 162.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.37% | -36.41% | 76.38% | 931.17% | 220.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,964.86% | 79.03% | 128.76% | 97.73% | 99.73% |